{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:52:58Z","timestamp":1773150778487,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1995,11,1]],"date-time":"1995-11-01T00:00:00Z","timestamp":815184000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[1995,11]]},"DOI":"10.1007\/bf00364979","type":"journal-article","created":{"date-parts":[[2004,11,4]],"date-time":"2004-11-04T23:42:20Z","timestamp":1099611740000},"page":"393-401","source":"Crossref","is-referenced-by-count":7,"title":["Prevention and therapy of fungal infections in cancer patients"],"prefix":"10.1007","volume":"3","author":[{"given":"J.","family":"Klastersky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/clinids\/18.3.298","volume":"18","author":"M Akova","year":"1994","unstructured":"Akova M, Akalin HE, Uzun O, et al (1994) Efficacy of fluconazole in the treatment of upper gastrointestinal candidiasis in neutropenic patients with cancer: factors influencing the outcome. Clin Infect Dis 18:298?304","journal-title":"Clin Infect Dis"},{"key":"CR2","first-page":"465","volume":"11","author":"M Besnard","year":"1993","unstructured":"Besnard M, Hartmann O, Valteau-Couanet D, et al (1993) Systemic candida infection in pediatric BM auto-transplantation: clinical signs, outcome and prognosis. Bone Marrow Transplant 11:465?470","journal-title":"Bone Marrow Transplant"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1128\/AAC.37.6.1367","volume":"37","author":"J Beyer","year":"1993","unstructured":"Beyer J, Barzen G, Risse G, et al (1993) Aerosol amophotericin B for prevention of invasive pulmonary aspergillosis. Antimicrob Agents Chemother 37:1367?1369","journal-title":"Antimicrob Agents Chemother"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1093\/clinids\/17.4.705","volume":"17","author":"GP Bodey","year":"1993","unstructured":"Bodey GP, Anaissic E, Gutterman J, et al (1993) Role of granulocyte-macrophage colony-stimulating factor as adjuvent therapy for fungal infection in patients with cancer. Clin Infect Dis 17:705?707","journal-title":"Clin Infect Dis"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00000441-199412000-00001","volume":"308","author":"A Chubachi","year":"1994","unstructured":"Chubachi A, Miura I, Ohshima A, et al (1994) Risk factors for hepatosplenic abscesses in patients with acute leukemia receiving empiric azole treatment. Am J Med Sci 308:309?312","journal-title":"Am J Med Sci"},{"key":"CR6","volume-title":"Antibiotic therapy in febrile neutropenic patients: what is the optimum duration of therapy? (Abstract 21)","author":"L Crane","year":"1988","unstructured":"Crane L, Komshian S, Sauber A, et al (1988) Antibiotic therapy in febrile neutropenic patients: what is the optimum duration of therapy? (Abstract 21). Proceedings of the 28th ICAAC, Los Angeles, Calif, 1988. American Society for Microbiology, Los Angeles"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0002-9343(94)90023-X","volume":"97","author":"DW Denning","year":"1994","unstructured":"Denning DW, Lee JY, Hostetler JS, et al (1994) NIAID mycoses study group multicenter trial of oral itraconazole therapy for invasive aspergillosis. Am J Med 97:135?144","journal-title":"Am J Med"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF00365855","volume":"3","author":"T Eggert","year":"1995","unstructured":"Eggert T, Gratwohl A, Tichelli A, et al (1995) Comparison of fluoconazole with oral polyenes in the prevention of fungal infections in neutropenic patients: a prospective, randomized, single-center study. Support Care Cancer 3:139?146","journal-title":"Support Care Cancer"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF01695916","volume":"68","author":"W Emminger","year":"1994","unstructured":"Emminger W, Graninger W, Emminger-Schmidmeier W, et al (1994) Tolerance of high doses of amphotericin B by infusion of a liposomal formulation in children with cancer. Ann Hematol 68:27?31","journal-title":"Ann Hematol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/0002-9343(89)90441-5","volume":"86","author":"EORTC International Antimicrobial Therapy Cooperative Group","year":"1989","unstructured":"EORTC International Antimicrobial Therapy Cooperative Group (1989) Empiric antifungal therapy in febrile granulocytopenic patients. Am J Med 86:668?672","journal-title":"Am J Med"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1001\/jama.1979.03300030030016","volume":"242","author":"EZ Ezdinli","year":"1979","unstructured":"Ezdinli EZ, O'Sullivan DD, Wasser LP, et al (1979) Oral amphotericin for candidiasis in patients with hematologic neoplasms. An autopsy study. JAMA 242:258?260","journal-title":"JAMA"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1001\/archinte.1992.00400140142030","volume":"152","author":"MT Flannery","year":"1992","unstructured":"Flannery MT, Simmons DB, Saba H, et al (1992) Fluconazole in the treatment of hepatosplenic candidiasis. Arch Intern Med 152:406?408","journal-title":"Arch Intern Med"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/clinids\/20.1.77","volume":"20","author":"DA Goff","year":"1995","unstructured":"Goff DA, Koletar SL, Buesching WJ, et al (1995) Isolation of fluconazoleresistant Candida albicans from human immunodeficiency virus-negative patients never treated with azoles. Clin Infect Dis 20:77?83","journal-title":"Clin Infect Dis"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1056\/NEJM199203263261301","volume":"326","author":"JL Goodman","year":"1992","unstructured":"Goodman JL, Winston DJ, Greenfield RA, et al (1992) A controlled tiral of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 326:845?851","journal-title":"N Engl J Med"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/clinids\/18.4.525","volume":"18","author":"HFL Guiot","year":"1994","unstructured":"Guiot HFL, Fibbe WE, Van't Wout JW (1994) Risk factors for fungal infection in patients with malignant hematologic disorders: implications for empirical therapy and prophylaxis. Clin Infect Dis 18:525?532","journal-title":"Clin Infect Dis"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1600-0609.1993.tb00617.x","volume":"51","author":"A Iwama","year":"1993","unstructured":"Iwama A, Yoshida M, Miwa A, et al (1993) Improved survival from fungaemia in patients with haematological malignancies: analysis of risk factors for death and usefulness of early antifungal therapy. Eur J Haematol 51:156?160","journal-title":"Eur J Haematol"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/clinids\/20.2.342","volume":"20","author":"PC Iwen","year":"1995","unstructured":"Iwen PC, Kelly DM, Reed EC, et al (1995) Invasive infection due to Candida krusei in immunocompromised patients not treated with fluconazole. Clin Infect Dis 20:342?347","journal-title":"Clin Infect Dis"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0002-9343(88)80343-7","volume":"85","author":"JE Karp","year":"1988","unstructured":"Karp JE, Burch PA, Merz WG (1988) An approach to intensive antileukemia therapy in patients with previous invasive aspergillosis. Am J Med 85:203?206","journal-title":"Am J Med"},{"key":"CR19","first-page":"46","volume":"12","author":"V Kremery Jr","year":"1994","unstructured":"Kremery V Jr, Studena M, Drgona L, et al (1994) New pathogens emerging in cancer patients as invasive fungal infections. Antiinfect Drugs Chemother 12:46?48","journal-title":"Antiinfect Drugs Chemother"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1001\/archinte.1989.00390110097022","volume":"149","author":"G Lopez-Berestein","year":"1989","unstructured":"Lopez-Berestein G, Bodey GP, Fainstein V, et al (1989) Treatment of systemic fungal infections with liposomal amphotericin B. Arch Intern Med 149:2533?2536","journal-title":"Arch Intern Med"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/BF00366042","volume":"1","author":"P Martino","year":"1993","unstructured":"Martino P, Girmenia C (1993) Diagnosis and treatment of invasive fungal infections in cancer patients. Support Care Cancer 1:240?244","journal-title":"Support Care Cancer"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"913","DOI":"10.7326\/0003-4819-120-11-199406010-00003","volume":"120","author":"F Menichetti","year":"1994","unstructured":"Menichetti F, Del Favero A, Martino P, et al (1994) Preventing fungal infection in neutropenic patients with acute leukemia: fluconazole compared with oral amphotericin B. Ann Intern Med 120:913?918","journal-title":"Ann Intern Med"},{"issue":"Suppl 7","key":"CR23","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1093\/clinids\/11.Supplement_7.S1605","volume":"11","author":"F Meunier","year":"1989","unstructured":"Meunier F (1989) New methods for delivery of antifungal agents. Rev Infect Dis 11 [Suppl 7]:1605?1612","journal-title":"Rev Infect Dis"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1002\/1097-0142(19931201)72:11<3223::AID-CNCR2820721115>3.0.CO;2-R","volume":"72","author":"P Moreau","year":"1993","unstructured":"Moreau P, Zahar JR, Milpied N, et al (1993) Localized invasive pulmonary aspergillosis in patients with neutropenia. Effectiveness of surgical resection. Cancer 72:3223?3226","journal-title":"Cancer"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0002-9343(94)90088-4","volume":"96","author":"VA Morrison","year":"1994","unstructured":"Morrison VA, Haake RJ, Weisdorf DJ (1994) Non-candida fungal infectitons after bone marrow transplantation: risk factors and outcome. Am J Med 96:497?503","journal-title":"Am J Med"},{"key":"CR26","unstructured":"Nemunaitis J, Shannon-Dorcy K, Appelbaum FR, et al (1993) Long-term follow-up of patients with invasive fungal disease who received adjunctive therapy with recombinant human macrophage colony-stimulating factor. Blood 1422?1427"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1200\/JCO.1994.12.4.827","volume":"12","author":"MR O'Donnell","year":"1994","unstructured":"O'Donnell MR, Schmidt GM, Tegtmeier BR, et al (1994) Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients. J Clin Oncol 12:827?834","journal-title":"J Clin Oncol"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/00001432-198908000-00012","volume":"2","author":"JR Perfect","year":"1989","unstructured":"Perfect JR (1989) Antifungal therapy 1989. Curr Opin Infect Dis 2:568?571","journal-title":"Curr Opin Infect Dis"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0002-9343(93)90053-R","volume":"94","author":"JR Perfect","year":"1993","unstructured":"Perfect JR (1993) Antifungal prophylaxis: to prevent or not (editorial). Am J Med 94:233?234","journal-title":"Am J Med"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/infdis\/165.5.891","volume":"165","author":"JR Perfeet","year":"1992","unstructured":"Perfeet JR, Klotman ME, Gilbert CC, et al (1992) Prophylaxis intravenous amphotericin B in neutropenic autologous bone marrow tranplant recipients. J Infect Dis 165:891?897","journal-title":"J Infect Dis"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/BF00344053","volume":"2","author":"E Pogliani","year":"1994","unstructured":"Pogliani E, Clini E (1994) Association therapy as a prognosis factor in deep fungal infection complication oncohaematological diseases. Support Care Cancer 2:385?388","journal-title":"Support Care Cancer"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1056\/NEJM199411173312001","volume":"331","author":"JH Rex","year":"1994","unstructured":"Rex JH, Bennett JE, Sugar AM, et al (1994) A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N Engl J Med 331:1325?1330","journal-title":"N Engl J Med"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1182\/blood.V84.4.1328.1328","volume":"84","author":"HG Sayer","year":"1994","unstructured":"Sayer HG, Longton G, Bowden R, et al (1994) Increased risk of infection in marrow transplant patients receiving methylprednisolone for graft-versus-host disease prevention. Blood 84:1328?1332","journal-title":"Blood"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1182\/blood.V81.7.1675.1675","volume":"81","author":"RG Strauss","year":"1993","unstructured":"Strauss RG (1993) Therapeutic granulocyte transfusions in 1993 (editorial). Blood 81:1675?1678","journal-title":"Blood"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"88","DOI":"10.7326\/0003-4819-108-1-88","volume":"108","author":"M Thaler","year":"1988","unstructured":"Thaler M, Pastakia B, Shawker TH, et al (1988) Hepatic candidiasis in cancer patients: the evolving picture of the syndrome. Ann Intern Med 108:88?100","journal-title":"Ann Intern Med"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1399-0012.1990.tb00047.x","volume":"4","author":"J Tollemar","year":"1990","unstructured":"Tollemar J, Ringden O, Tyden G (1990) Liposomal amphotericin B (AmBisome) treatment in solid organ and bone marrow transplant recipients. Efficacy and safety evolution. Clin Transplant 4:167?175","journal-title":"Clin Transplant"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/oxfordjournals.annonc.a058877","volume":"5","author":"AT Tomiak","year":"1994","unstructured":"Tomiak AT, Yau JC, Huan SD, et al (1994) Duration of intravenous antibiotics for patients with neutropenic fever. Ann Oncol 5:441?445","journal-title":"Ann Oncol"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/infdis\/168.1.195","volume":"168","author":"JA Vasquez","year":"1993","unstructured":"Vasquez JA, Sanchez V, Dmuchowski C, et al (1993) Nosocomial acquisition of Candida albicans: an epidemiologic study. J Infect Dis 168:195?201","journal-title":"J Infect Dis"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/BF01962595","volume":"7","author":"TJ Walsh","year":"1988","unstructured":"Walsh TJ, Pizzo A (1988) Treatment of systemic fungal infections: recent progress and current problems. Eur J Clin Microbiol Infect Dis 7:460?475","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/clinids\/18.5.793","volume":"18","author":"TJ Walsh","year":"1994","unstructured":"Walsh TJ, Hiemenz J, Pizzo PA (1994) Editorial response: evolving risk factors for invasive fungal infections. All neutropenic patients are not the same. Clin Infect Dis 18:793?798","journal-title":"Clin Infect Dis"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/clinids\/20.1.115","volume":"20","author":"JR Wingard","year":"1995","unstructured":"Wingard JR (1995) Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin Infect Dis 20:115?125","journal-title":"Clin Infect Dis"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"495","DOI":"10.7326\/0003-4819-118-7-199304010-00003","volume":"118","author":"DJ Winston","year":"1993","unstructured":"Winston DJ, Chandrasekar PH, Lazarus HM (1993) Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, doubleblind, multicenter trial. Ann Intern Med 118:495?503","journal-title":"Ann Intern Med"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00364979.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00364979\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00364979","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T18:00:28Z","timestamp":1734631228000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00364979"}},"subtitle":["A review of recently published information"],"short-title":[],"issued":{"date-parts":[[1995,11]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1995,11]]}},"alternative-id":["BF00364979"],"URL":"https:\/\/doi.org\/10.1007\/bf00364979","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,11]]}}}